Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)

A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of hematology 2017-07, Vol.106 (1), p.138-140
Hauptverfasser: Shimizu, Takuya, Hatanaka, Kazuo, Kaneko, Hitomi, Shimada, Toshihide, Imada, Kazunori
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 140
container_issue 1
container_start_page 138
container_title International journal of hematology
container_volume 106
creator Shimizu, Takuya
Hatanaka, Kazuo
Kaneko, Hitomi
Shimada, Toshihide
Imada, Kazunori
description A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.
doi_str_mv 10.1007/s12185-017-2191-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1866291921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1911523986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</originalsourceid><addsrcrecordid>eNp1kU1P3DAQhq2qVdnS_oBeKku9LAeDx1nH8RGWFpBWKodythxnDEb5WOyEj39frwKoQuI0suaZd8bvS8h34IfAuTpKIKCSjINiAjQw9YEsoColK5RafSQLroVkUgHfI19SuuUZ5Cv1meyJClQpRLUgj5cxdDY-0WnEGHqkTfB-SkhbG6-RnjCHbUvbp257M3SWLk83J-vNAQ09tXRrx4D9SB_CeEO3cWiH_hqb3EsYxzD0dPD5MUb7qo33wSFdXlydHnwln7xtE357rvvk6vevv-tztvlzdrE-3jBX6HJkDRaFA-8r7aF2uvS1qOTKcidrx6X20jY1IkhvoVTKNZ4jKHBQNrVoYKWLfbKcdfOBdxOm0XQh7T5lexymZLJfpdCgBWT05xv0dphin68z2V2QotBVmSmYKReHlCJ6s50tNMDNLhYzx2Ky22YXi1F55sez8lR32LxOvOSQATEDKbeyi_G_1e-q_gNVyJgO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911523986</pqid></control><display><type>article</type><title>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Shimizu, Takuya ; Hatanaka, Kazuo ; Kaneko, Hitomi ; Shimada, Toshihide ; Imada, Kazunori</creator><creatorcontrib>Shimizu, Takuya ; Hatanaka, Kazuo ; Kaneko, Hitomi ; Shimada, Toshihide ; Imada, Kazunori</creatorcontrib><description>A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-017-2191-7</identifier><identifier>PMID: 28176228</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>B-cell lymphoma ; Biopsy ; Bleeding ; Case Report ; Combined Modality Therapy ; Female ; Hematology ; Humans ; Immunohistochemistry ; Insertion ; Intrauterine devices ; Intrauterine Devices - adverse effects ; IUD ; Lymphocytes B ; Lymphoma ; Lymphoma, Large B-Cell, Diffuse - diagnosis ; Lymphoma, Large B-Cell, Diffuse - etiology ; Lymphoma, Large B-Cell, Diffuse - therapy ; Magnetic Resonance Imaging - methods ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Monoclonal antibodies ; Oncology ; Polyps ; Radiation ; Radiation therapy ; Remission ; Rituximab ; Smell ; Targeted cancer therapy ; Treatment Outcome ; Uterine Neoplasms - diagnosis ; Uterine Neoplasms - etiology ; Uterine Neoplasms - therapy ; Uterus ; Vagina</subject><ispartof>International journal of hematology, 2017-07, Vol.106 (1), p.138-140</ispartof><rights>The Japanese Society of Hematology 2017</rights><rights>International Journal of Hematology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</citedby><cites>FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</cites><orcidid>0000-0002-0945-0513</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12185-017-2191-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12185-017-2191-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28176228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimizu, Takuya</creatorcontrib><creatorcontrib>Hatanaka, Kazuo</creatorcontrib><creatorcontrib>Kaneko, Hitomi</creatorcontrib><creatorcontrib>Shimada, Toshihide</creatorcontrib><creatorcontrib>Imada, Kazunori</creatorcontrib><title>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.</description><subject>B-cell lymphoma</subject><subject>Biopsy</subject><subject>Bleeding</subject><subject>Case Report</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Insertion</subject><subject>Intrauterine devices</subject><subject>Intrauterine Devices - adverse effects</subject><subject>IUD</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Lymphoma, Large B-Cell, Diffuse - diagnosis</subject><subject>Lymphoma, Large B-Cell, Diffuse - etiology</subject><subject>Lymphoma, Large B-Cell, Diffuse - therapy</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Monoclonal antibodies</subject><subject>Oncology</subject><subject>Polyps</subject><subject>Radiation</subject><subject>Radiation therapy</subject><subject>Remission</subject><subject>Rituximab</subject><subject>Smell</subject><subject>Targeted cancer therapy</subject><subject>Treatment Outcome</subject><subject>Uterine Neoplasms - diagnosis</subject><subject>Uterine Neoplasms - etiology</subject><subject>Uterine Neoplasms - therapy</subject><subject>Uterus</subject><subject>Vagina</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU1P3DAQhq2qVdnS_oBeKku9LAeDx1nH8RGWFpBWKodythxnDEb5WOyEj39frwKoQuI0suaZd8bvS8h34IfAuTpKIKCSjINiAjQw9YEsoColK5RafSQLroVkUgHfI19SuuUZ5Cv1meyJClQpRLUgj5cxdDY-0WnEGHqkTfB-SkhbG6-RnjCHbUvbp257M3SWLk83J-vNAQ09tXRrx4D9SB_CeEO3cWiH_hqb3EsYxzD0dPD5MUb7qo33wSFdXlydHnwln7xtE357rvvk6vevv-tztvlzdrE-3jBX6HJkDRaFA-8r7aF2uvS1qOTKcidrx6X20jY1IkhvoVTKNZ4jKHBQNrVoYKWLfbKcdfOBdxOm0XQh7T5lexymZLJfpdCgBWT05xv0dphin68z2V2QotBVmSmYKReHlCJ6s50tNMDNLhYzx2Ky22YXi1F55sez8lR32LxOvOSQATEDKbeyi_G_1e-q_gNVyJgO</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Shimizu, Takuya</creator><creator>Hatanaka, Kazuo</creator><creator>Kaneko, Hitomi</creator><creator>Shimada, Toshihide</creator><creator>Imada, Kazunori</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0945-0513</orcidid></search><sort><creationdate>20170701</creationdate><title>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</title><author>Shimizu, Takuya ; Hatanaka, Kazuo ; Kaneko, Hitomi ; Shimada, Toshihide ; Imada, Kazunori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>B-cell lymphoma</topic><topic>Biopsy</topic><topic>Bleeding</topic><topic>Case Report</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Insertion</topic><topic>Intrauterine devices</topic><topic>Intrauterine Devices - adverse effects</topic><topic>IUD</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Lymphoma, Large B-Cell, Diffuse - diagnosis</topic><topic>Lymphoma, Large B-Cell, Diffuse - etiology</topic><topic>Lymphoma, Large B-Cell, Diffuse - therapy</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Monoclonal antibodies</topic><topic>Oncology</topic><topic>Polyps</topic><topic>Radiation</topic><topic>Radiation therapy</topic><topic>Remission</topic><topic>Rituximab</topic><topic>Smell</topic><topic>Targeted cancer therapy</topic><topic>Treatment Outcome</topic><topic>Uterine Neoplasms - diagnosis</topic><topic>Uterine Neoplasms - etiology</topic><topic>Uterine Neoplasms - therapy</topic><topic>Uterus</topic><topic>Vagina</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimizu, Takuya</creatorcontrib><creatorcontrib>Hatanaka, Kazuo</creatorcontrib><creatorcontrib>Kaneko, Hitomi</creatorcontrib><creatorcontrib>Shimada, Toshihide</creatorcontrib><creatorcontrib>Imada, Kazunori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimizu, Takuya</au><au>Hatanaka, Kazuo</au><au>Kaneko, Hitomi</au><au>Shimada, Toshihide</au><au>Imada, Kazunori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>106</volume><issue>1</issue><spage>138</spage><epage>140</epage><pages>138-140</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>28176228</pmid><doi>10.1007/s12185-017-2191-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0945-0513</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0925-5710
ispartof International journal of hematology, 2017-07, Vol.106 (1), p.138-140
issn 0925-5710
1865-3774
language eng
recordid cdi_proquest_miscellaneous_1866291921
source MEDLINE; SpringerLink Journals
subjects B-cell lymphoma
Biopsy
Bleeding
Case Report
Combined Modality Therapy
Female
Hematology
Humans
Immunohistochemistry
Insertion
Intrauterine devices
Intrauterine Devices - adverse effects
IUD
Lymphocytes B
Lymphoma
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - etiology
Lymphoma, Large B-Cell, Diffuse - therapy
Magnetic Resonance Imaging - methods
Medicine
Medicine & Public Health
Middle Aged
Monoclonal antibodies
Oncology
Polyps
Radiation
Radiation therapy
Remission
Rituximab
Smell
Targeted cancer therapy
Treatment Outcome
Uterine Neoplasms - diagnosis
Uterine Neoplasms - etiology
Uterine Neoplasms - therapy
Uterus
Vagina
title Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T15%3A00%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20uterine%20diffuse%20large%20B-cell%20lymphoma%20(DLBCL)%20in%20a%20patient%20with%20prolonged%20insertion%20of%20intrauterine%20device%20(IUD)&rft.jtitle=International%20journal%20of%20hematology&rft.au=Shimizu,%20Takuya&rft.date=2017-07-01&rft.volume=106&rft.issue=1&rft.spage=138&rft.epage=140&rft.pages=138-140&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-017-2191-7&rft_dat=%3Cproquest_cross%3E1911523986%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911523986&rft_id=info:pmid/28176228&rfr_iscdi=true